Quantum Computing Inc. ends the week with a fresh analyst upgrade on one side and an utterly frozen lending market on the other — the same extreme tension flagged three days ago, now with new Street activity adding a layer of contrast.
The most notable development since Monday's note is on the analyst front. Ascendiant Capital raised its price target on QUBT to $32 from $30 just this morning, maintaining a Buy rating — the second target lift from the same firm in roughly ten weeks. The broader Street remains split: Rosenblatt holds a $22 Buy, Northland initiated at Outperform with a $20 target in April, while Cantor Fitzgerald and Wedbush both sit at Neutral with targets of $10 and $12 respectively. That divide maps neatly onto the bull and bear cases. Bulls point to the deployment-ready NeuraWave platform, the delivered Dirac-3 system, and a fresh purchase order for quantum secure communications as evidence that revenue is finally becoming real. Bears counter that IBM, Google, Amazon, and Microsoft are spending at a scale QUBT cannot match, that the path to profitability remains distant, and that the NHanced Semiconductors acquisition is still unproven. The mean target of $18.67 implies more than 120% upside to the $8.46 close — but with two neutrals anchoring the low end and the stock unprofitable on every reported metric, that average is doing a lot of heavy lifting.
The lending market has not moved at all. Availability remains at zero — every share in the borrow pool is already lent out, and has been without interruption since mid-July. Short interest is 28.7% of the free float, roughly 64.3 million shares, fractionally higher than the 28.5% reported in Monday's note. Cost to borrow has drifted up slightly to 10.5% after touching a brief low, but the broader trend over the past six weeks has been a steady decline from the mid-July peak near 16%. That easing in borrow cost with zero availability is the same equilibrium dynamic noted earlier in the week: shorts are not being forced out, but new shorts cannot easily be added either. The ORTEX short score of 78.7 — ranking in the bottom 1st percentile of the universe on both short score and availability — has edged higher across every session this week, a quiet but consistent drift toward more extreme positioning.
Options tell a different story from the short book. The put/call ratio has dropped to 0.58, nearly 1.7 standard deviations below its 20-day average of 0.66 and close to the lowest reading of the past year. Call volume is running well ahead of put volume, suggesting options traders are positioned for upside rather than protection — a stance that sits in direct tension with the 28%-plus short interest. That gap between the options market and the short book is the central question for QUBT right now: one community is actively buying upside exposure while the other has committed nearly a third of the float to the bear side, and both face near-impossible conditions to reverse course quickly given zero borrow availability.
On the ownership side, BlackRock added 1.6 million shares in its most recent filing, and Penserra Capital added 3.6 million — the largest institutional add in the top-holder list. Top holder Yuping Huang remains at 10.5% of shares with a modest recent add of 585,000 shares. Insider data is stale beyond the 90-day window, with the most recent disclosed trades being CFO sales in March at prices around $7.85 — modestly below today's close, which provides some context on where management was trimming.
Valuation multiples are uniformly negative given the company's loss-making status — price-to-earnings is deeply negative and EV/EBITDA is meaningless — leaving the price-to-book ratio of 2.3x as the only conventional anchor, itself down modestly over the past month. The next scheduled earnings event is November 13, giving the current setup roughly eleven weeks to play out before the next fundamental reset.
With availability still at zero, the short score nudging higher, and the first incremental analyst action of the week pushing a target well above the current price, the next test for QUBT is whether the growing call-side positioning in options can draw enough momentum interest to stress a short base that has no obvious exit.
See the live data behind this article on ORTEX.
Open QUBT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
